USANA Health Sciences (NYSE:USNA) Stock Price Down 6% - Here's Why

USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report) shares fell 6% during trading on Friday . The stock traded as low as $33.00 and last traded at $32.77. Approximately 68,031 shares traded hands during trading, a decline of 41% from the average daily volume of 116,075 shares. The stock had previously closed at $34.86.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on USNA shares. DA Davidson lifted their price target on shares of USANA Health Sciences from $35.00 to $38.00 and gave the company a "neutral" rating in a research note on Thursday, January 2nd. StockNews.com raised USANA Health Sciences from a "buy" rating to a "strong-buy" rating in a research report on Saturday, December 28th.

USANA Health Sciences Price Performance

The firm has a market capitalization of $602.33 million, a P/E ratio of 11.17, a PEG ratio of 0.88 and a beta of 0.87. The firm's 50 day moving average is $35.61 and its two-hundred day moving average is $37.78.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Pzena Investment Management LLC lifted its stake in USANA Health Sciences by 7.5% in the 3rd quarter. Pzena Investment Management LLC now owns 1,049,610 shares of the company's stock valued at $39,801,000 after purchasing an additional 72,977 shares during the last quarter. Pacer Advisors Inc. lifted its position in shares of USANA Health Sciences by 8.8% in the fourth quarter. Pacer Advisors Inc. now owns 592,001 shares of the company's stock valued at $21,247,000 after buying an additional 47,745 shares during the last quarter. State Street Corp lifted its position in shares of USANA Health Sciences by 0.6% in the third quarter. State Street Corp now owns 435,164 shares of the company's stock valued at $16,501,000 after buying an additional 2,782 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of USANA Health Sciences by 4.5% during the 3rd quarter. Geode Capital Management LLC now owns 297,120 shares of the company's stock worth $11,269,000 after acquiring an additional 12,898 shares during the last quarter. Finally, Assenagon Asset Management S.A. raised its stake in USANA Health Sciences by 13.5% in the 3rd quarter. Assenagon Asset Management S.A. now owns 124,008 shares of the company's stock valued at $4,702,000 after acquiring an additional 14,756 shares during the period. Institutional investors own 54.25% of the company's stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.